Literature DB >> 2166814

Genetic mapping of the ability of Theiler's virus to persist and demyelinate.

A McAllister1, F Tangy, C Aubert, M Brahic.   

Abstract

Theiler's virus, a murine picornavirus, is responsible for two different types of disease: strains DA, BeAn, and WW persist for more than a year in the white matter of the central nervous system and cause primary demyelination; strains GDVII and FA, on the other hand, cause an acute encephalitis that kills the host in a matter of days. To map the regions of the viral genome responsible for persistence and demyelination, cDNA clones of the entire genomes of the DA and GDVII strains were constructed and cloned into Bluescript plasmid (A. McAllister, F. Tangy, C. Aubert, and M. Brahic, Microb. Pathogen. 7:381-388, 1989; F. Tangy, A. McAllister, and M. Brahic, J. Virol. 63:1101-1106, 1989). We constructed chimeric viruses obtained by exchanging regions between the cDNA clones. Analysis of the disease phenotypes produced by the chimeric viruses allowed us to map persistence and demyelination to a genome segment coding for the VP1 capsid protein and 27 amino acids of protein 2A.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166814      PMCID: PMC247890          DOI: 10.1128/JVI.64.9.4252-4257.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Theiler's virus infection in mice: an unusual biphasic disease process leading to demyelination.

Authors:  H L Lipton
Journal:  Infect Immun       Date:  1975-05       Impact factor: 3.441

2.  Central nervous system immunity in mice infected with theiler's virus. I. Local neutralizing antibody response.

Authors:  H L Lipton; F Gonzalez-Scarano
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

3.  Structure of a human common cold virus and functional relationship to other picornaviruses.

Authors:  M G Rossmann; E Arnold; J W Erickson; E A Frankenberger; J P Griffith; H J Hecht; J E Johnson; G Kamer; M Luo; A G Mosser
Journal:  Nature       Date:  1985 Sep 12-18       Impact factor: 49.962

4.  Simultaneous in situ detection of viral RNA and antigens.

Authors:  M Brahic; A T Haase; E Cash
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

5.  Detection of mrnas in sea urchin embryos by in situ hybridization using asymmetric RNA probes.

Authors:  K H Cox; D V DeLeon; L M Angerer; R C Angerer
Journal:  Dev Biol       Date:  1984-02       Impact factor: 3.582

6.  Persistent Theiler's murine encephalomyelitis virus infection in mice depends on plaque size.

Authors:  H L Lipton
Journal:  J Gen Virol       Date:  1980-01       Impact factor: 3.891

7.  Primary demyelination in Theiler's virus infection. An ultrastructural study.

Authors:  M C Dal Canto; H L Lipton
Journal:  Lab Invest       Date:  1975-12       Impact factor: 5.662

8.  Molecular cloning of the complete genome of Theiler's virus, strain DA, and production of infectious transcripts.

Authors:  A McAllister; F Tangy; C Aubert; M Brahic
Journal:  Microb Pathog       Date:  1989-11       Impact factor: 3.738

9.  Detection of Theiler's virus RNA in mouse central nervous system by in situ hybridization.

Authors:  W G Stroop; J R Baringer; M Brahic
Journal:  Lab Invest       Date:  1981-12       Impact factor: 5.662

10.  Demyelinative myelopathy in mice induced by the DA virus.

Authors:  J R Lehrich; B G Arnason; F H Hochberg
Journal:  J Neurol Sci       Date:  1976-10       Impact factor: 3.181

View more
  45 in total

1.  The GDVII strain of Theiler's virus spreads via axonal transport.

Authors:  C Martinat; N Jarousse; M C Prévost; M Brahic
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Analysis of cellular mutants resistant to Theiler's virus infection: differential infection of L929 cells by persistent and neurovirulent strains.

Authors:  K Jnaoui; T Michiels
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

3.  A coding RNA sequence acts as a replication signal in cardioviruses.

Authors:  P E Lobert; N Escriou; J Ruelle; T Michiels
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

4.  Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection.

Authors:  Stéphanie Aubagnac; Michel Brahic; Jean-François Bureau
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Influence of the Theiler's virus L* protein on macrophage infection, viral persistence, and neurovirulence.

Authors:  O van Eyll; T Michiels
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

6.  Infection with Theiler's murine encephalomyelitis virus directly induces proinflammatory cytokines in primary astrocytes via NF-kappaB activation: potential role for the initiation of demyelinating disease.

Authors:  JoAnn P Palma; Daeho Kwon; Neil A Clipstone; Byung S Kim
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Non-AUG-initiated internal translation of the L* protein of Theiler's virus and importance of this protein for viral persistence.

Authors:  Olivier van Eyll; Thomas Michiels
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

8.  The interaction of two groups of murine genes determines the persistence of Theiler's virus in the central nervous system.

Authors:  J F Bureau; X Montagutelli; S Lefebvre; J L Guénet; M Pla; M Brahic
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

9.  Virus persistence in an animal model of multiple sclerosis requires virion attachment to sialic acid coreceptors.

Authors:  A S Manoj Kumar; Honey V Reddi; Aisha Y Kung; Mauro Dal Canto; Howard L Lipton
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Infection of macrophage primary cultures by persistent and nonpersistent strains of Theiler's virus: role of capsid and noncapsid viral determinants.

Authors:  Ignacio Mena; Jean-Pierre Roussarie; Michel Brahic
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.